Mather Group, Llc. Sarepta Therapeutics, Inc. Transaction History
Mather Group, Llc.
- $7.74 Billion
- Q3 2024
A detailed history of Mather Group, Llc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 213 shares of SRPT stock, worth $26,277. This represents 0.0% of its overall portfolio holdings.
Number of Shares
213
Previous 248
14.11%
Holding current value
$26,277
Previous $39,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.2MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.27 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.11 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$772 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$538 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$527 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.8B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...